All stock lists
Unlock the score
Precision Biosciences Inc (NASDAQ:DTIL)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
6.41-0.23 (-3.46%)
Market cap
$177M
Insider Score
Health Score
Analyst consensus
Listed since
Mar 28, 2019
Website
Insider Score
/ 100
DTIL Insider Score
PRECISION BIOSCIENCES INC has a live Insider Score.
Scored on 3 qualifying trades from 3 insiders in the last 90 days.
DTIL analyst forecast
DTIL analyst consensus
Moderate Buy1 ratings
Buy 1 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
DTIL 12-month price target
No published price targets in the last 12 months.
Best analysts covering DTIL
- HC Wainwright & Co.19%success rate · 16 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
DTIL analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-08-03 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-07-09 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-05-27 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-05-21 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-03-28 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-03-19 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-02-19 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-01-10 |
| — | BMO Capital | Outperform | — | — | Upgraded | 2025-01-10 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-05-30 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-05-16 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-04-17 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-03-28 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-02-14 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-09-18 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-08-16 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-07-27 |
| — | BTIG | Buy | — | — | Reiterated | 2023-07-27 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-05-31 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-03-15 |
| — | BMO Capital | Market Perform | — | — | Downgraded | 2023-03-13 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2022-11-09 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2022-11-09 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2022-08-08 |
| — | BMO Capital | Outperform | — | — | Reiterated | 2022-06-17 |
| — | William Blair | Market Perform | — | — | Downgraded | 2022-06-08 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2022-03-15 |
| — | Stifel | Buy | — | — | Reiterated | 2021-09-09 |
| — | JonesTrading | Buy | — | — | Reiterated | 2021-02-24 |
| — | JP Morgan | Neutral | — | — | Downgraded | 2020-12-06 |
| — | Goldman Sachs | Neutral | — | — | Downgraded | 2020-04-02 |
| — | H.C. Wainwright | Buy | — | — | Reiterated | 2020-03-11 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2020-03-10 |
| — | Stifel Nicolaus | Buy | — | — | Reiterated | 2020-03-05 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2019-04-22 |
| — | Jefferies | Buy | — | — | Reiterated | 2019-04-22 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2019-04-22 |
| — | Barclays | Overweight | — | — | Reiterated | 2019-04-22 |
DTIL earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-12 | -0.21 | 1.05 | $9.1M | $34.2M |
| 2026-05-05 | -0.27 | -0.75 | $4.0M | $10.8M |
| 2026-08-06 | -0.80 | -1.26 | $740K | $0 |
| 2026-11-02 | -0.85 | 0.00 | $1.4M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.